Dr. Kateryna Kon, MD, PhD, currently works at the Department of Microbiology, Virology and Immunology at Kharkiv National Medical University, Kharkiv, Ukraine as an Associate Professor. Dr. Kon received the Best Young Scientist of Kharkiv Award in 2007. She has ten years of teaching and fifteen years of research experience. She is an editorial board member of six international peer-reviewed journals. Dr. Kon's scientific contributions include more than 100 publications, 6 books and 18 scientific articles. The main focus of Dr. Kon’s research is antibiotic resistance in bacteria, coping with microbial resistance by plant essential oils and nanoparticles, microbiology of surgical and gynaecological infections, application of different statistical methods to analysis of biomedical data. Mahendra Rai is an internationally recognized scholar with extensive contributions to microbial biotechnology and nanobiotechnology research, particularly in the green synthesis of metal nanoparticles using fungi and their application as nano‑antimicrobials. His work is highly interdisciplinary, bridging microbiology, biotechnology, and nanoscience, and he is an active member of several scientific societies. He has received multiple national and international distinctions, including the Father T.A. Mathias Award from the All-India Association for Christian Higher Education and the Medini Award from the Government of India. Professor Rai has also held numerous visiting scientist and visiting professor positions across Europe, South America, and Asia, contributing to long‑standing research collaborations in countries such as Brazil, Argentina, Hungary, Switzerland, Italy, Germany, and the United States. His sustained academic impact is reflected in his inclusion among the global top 2% of scientists in nanoscience and nanotechnology, and recognition as one of India’s leading researchers in biology and biochemistry, including a Biology and Biochemistry India Leader Award from Research.com.

• Chapter 1: Influenza virus infections: clinical update, molecular biology, and therapeutic optionsChapter 2: Influenza viral infection in the respiratory system—potential ways of monitoringChapter 3: SARS coronavirus infections of the lower respiratory tract and their preventionChapter 4: The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsulaChapter 5: Respiratory infections of the human bocavirusChapter 6: Circulation of respiratory pathogens at mass gatherings, with special focus on the Hajj pilgrimageChapter 7: Indoor air pollution due to mycoflora causing acute lower respiratory infectionsChapter 8: Is there a link between environmental allergens and parasitism?Chapter 9: Respiratory infections in immunosuppressed patientsChapter 10: Metallo-beta-lactamase producer Pseudomonas aeruginosa: an opportunistic pathogen in lungsChapter 11: Mycobacterium tuberculosis: clinical and microbiological aspectsChapter 12: Pulmonary aspergillosis: diagnosis and treatmentChapter 13: Laboratory diagnosis of Pneumocystis jirovecii pneumoniaChapter 14: Antimicrobial approaches against bacterial pathogens which cause lower respiratory system infectionsChapter 15: Nanotechnological applications for the control of pulmonary infectionsChapter 16: Volatile oils: Potential agents for the treatment of respiratory infectionsChapter 17: Current therapeutics and prophylactic approaches to treat pneumonia

Dr. Kateryna Kon, MD, PhD, currently works at the Department of Microbiology, Virology and Immunology at Kharkiv National Medical University, Kharkiv, Ukraine as an Associate Professor. Dr. Kon received the Best Young Scientist of Kharkiv Award in 2007. She has ten years of teaching and fifteen years of research experience. She is an editorial board member of six international peer-reviewed journals. Dr. Kon's scientific contributions include more than 100 publications, 6 books and 18 scientific articles. The main focus of Dr. Kon’s research is antibiotic resistance in bacteria, coping with microbial resistance by plant essential oils and nanoparticles, microbiology of surgical and gynaecological infections, application of different statistical methods to analysis of biomedical data. Mahendra Rai is an internationally recognized scholar with extensive contributions to microbial biotechnology and nanobiotechnology research, particularly in the green synthesis of metal nanoparticles using fungi and their application as nano‑antimicrobials. His work is highly interdisciplinary, bridging microbiology, biotechnology, and nanoscience, and he is an active member of several scientific societies. He has received multiple national and international distinctions, including the Father T.A. Mathias Award from the All-India Association for Christian Higher Education and the Medini Award from the Government of India. Professor Rai has also held numerous visiting scientist and visiting professor positions across Europe, South America, and Asia, contributing to long‑standing research collaborations in countries such as Brazil, Argentina, Hungary, Switzerland, Italy, Germany, and the United States. His sustained academic impact is reflected in his inclusion among the global top 2% of scientists in nanoscience and nanotechnology, and recognition as one of India’s leading researchers in biology and biochemistry, including a Biology and Biochemistry India Leader Award from Research.com.

• Chapter 1: Influenza virus infections: clinical update, molecular biology, and therapeutic optionsChapter 2: Influenza viral infection in the respiratory system—potential ways of monitoringChapter 3: SARS coronavirus infections of the lower respiratory tract and their preventionChapter 4: The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsulaChapter 5: Respiratory infections of the human bocavirusChapter 6: Circulation of respiratory pathogens at mass gatherings, with special focus on the Hajj pilgrimageChapter 7: Indoor air pollution due to mycoflora causing acute lower respiratory infectionsChapter 8: Is there a link between environmental allergens and parasitism?Chapter 9: Respiratory infections in immunosuppressed patientsChapter 10: Metallo-beta-lactamase producer Pseudomonas aeruginosa: an opportunistic pathogen in lungsChapter 11: Mycobacterium tuberculosis: clinical and microbiological aspectsChapter 12: Pulmonary aspergillosis: diagnosis and treatmentChapter 13: Laboratory diagnosis of Pneumocystis jirovecii pneumoniaChapter 14: Antimicrobial approaches against bacterial pathogens which cause lower respiratory system infectionsChapter 15: Nanotechnological applications for the control of pulmonary infectionsChapter 16: Volatile oils: Potential agents for the treatment of respiratory infectionsChapter 17: Current therapeutics and prophylactic approaches to treat pneumonia

Dr. Kateryna Kon, MD, PhD, currently works at the Department of Microbiology, Virology and Immunology at Kharkiv National Medical University, Kharkiv, Ukraine as an Associate Professor. Dr. Kon received the Best Young Scientist of Kharkiv Award in 2007. She has ten years of teaching and fifteen years of research experience. She is an editorial board member of six international peer-reviewed journals. Dr. Kon's scientific contributions include more than 100 publications, 6 books and 18 scientific articles. The main focus of Dr. Kon’s research is antibiotic resistance in bacteria, coping with microbial resistance by plant essential oils and nanoparticles, microbiology of surgical and gynaecological infections, application of different statistical methods to analysis of biomedical data. Mahendra Rai is an internationally recognized scholar with extensive contributions to microbial biotechnology and nanobiotechnology research, particularly in the green synthesis of metal nanoparticles using fungi and their application as nano‑antimicrobials. His work is highly interdisciplinary, bridging microbiology, biotechnology, and nanoscience, and he is an active member of several scientific societies. He has received multiple national and international distinctions, including the Father T.A. Mathias Award from the All-India Association for Christian Higher Education and the Medini Award from the Government of India. Professor Rai has also held numerous visiting scientist and visiting professor positions across Europe, South America, and Asia, contributing to long‑standing research collaborations in countries such as Brazil, Argentina, Hungary, Switzerland, Italy, Germany, and the United States. His sustained academic impact is reflected in his inclusion among the global top 2% of scientists in nanoscience and nanotechnology, and recognition as one of India’s leading researchers in biology and biochemistry, including a Biology and Biochemistry India Leader Award from Research.com.

• Chapter 1: Influenza virus infections: clinical update, molecular biology, and therapeutic optionsChapter 2: Influenza viral infection in the respiratory system—potential ways of monitoringChapter 3: SARS coronavirus infections of the lower respiratory tract and their preventionChapter 4: The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsulaChapter 5: Respiratory infections of the human bocavirusChapter 6: Circulation of respiratory pathogens at mass gatherings, with special focus on the Hajj pilgrimageChapter 7: Indoor air pollution due to mycoflora causing acute lower respiratory infectionsChapter 8: Is there a link between environmental allergens and parasitism?Chapter 9: Respiratory infections in immunosuppressed patientsChapter 10: Metallo-beta-lactamase producer Pseudomonas aeruginosa: an opportunistic pathogen in lungsChapter 11: Mycobacterium tuberculosis: clinical and microbiological aspectsChapter 12: Pulmonary aspergillosis: diagnosis and treatmentChapter 13: Laboratory diagnosis of Pneumocystis jirovecii pneumoniaChapter 14: Antimicrobial approaches against bacterial pathogens which cause lower respiratory system infectionsChapter 15: Nanotechnological applications for the control of pulmonary infectionsChapter 16: Volatile oils: Potential agents for the treatment of respiratory infectionsChapter 17: Current therapeutics and prophylactic approaches to treat pneumonia